Safety of COVID-19 Patients and Use of Medicines without Scientific Evidence of Their Benefit, 26 May 2020
MetadataShow full item record
Other Language Versions
COVID-19 treatment options currently under study include several antiviral drugs and immune modulators, the antimalarials chloroquine and hydroxychloroquine, corticosteroids, convalescent plasma, pharmaceutical products that target the renin-angiotensin system, hyperbaric oxygen, and nitric oxide, among many others. However, except for remdesivir, which underwent a clinical trial that showed some preliminary positive results, a systematic review by the Pan American Health Organization has so far failed to identify a treatment option that can effectively address the causative agent of COVID-19. The same can be said with regard to prophylaxis. PAHO and WHO are regularly publishing up-to-date summaries of available evidence on the effectiveness of these interventions.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Pan American Health Organization; Health Emergencies (PHE) (Washington, D.C., PAHO, 2021-11-09)This report documents PAHO’s efforts in the first six months of 2021, period in which the Organization continued responding to emerging needs in the Americas Region to detect, track, treat and slow the spread of COVID-19; ...
SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil Rodrigues Campos, Karoline; Tavares Sacchi, Cláudio; Abbud, Adriano; Caterino-de-Araujo, Adele (2021-09-15)[ABSTRACT]. COVID-19 vaccination began in São Paulo, Brazil in January 2021, first targeting healthcare workers (HCWs) and the elderly, using the CoronaVac vaccine (Sinovac/Butantan) and subsequently the Oxford/AstraZeneca ...
Taborda R., Alejandra; Murillo, Diego Alejandro; Moreno L., Carolina; Taborda R., Paula Andrea; Fuquen, Marcela; Díaz, Paula Andrea; Londoño, Darío (2022-01-11)[RESUMEN]. Objetivo. Estimar el impacto presupuestal de la vacunación contra COVID-19 en seis países de América Latina: Argentina, Brasil, Chile, Colombia, México y Perú, durante el periodo 2021-2022. Métodos. Se evaluaron ...